Skip to main content

Summit Rock Advisors, LP

SEC CIK
0001540951
Latest filing
Aug 4, 2026

Holdings in Q3 2022

Holdings as of Sep 30, 2022, filed Nov 2, 2022. Long positions only; changes compare share counts with Q2 2022.

Institution overview
Positions
5
−3 vs. Q2 2022
Portfolio value
$128.1M
+$5.73M (+4.7%) vs. Q2 2022
Filed
Nov 2, 2022
SEC
Holdings of Summit Rock Advisors, LP in Q3 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
State Street Energy Select Sector SPDR ETF81369Y506ETF1,084,604$78.1M61.0%+241,335+28.6%Added–
iShares Tr464287630RUS 2000 VAL ETF338,862$43.7M34.1%−81,138−19.3%Reduced–
Vanguard Total World Stock ETF922042742ETF66,600$5.25M4.1%+35,271+112.6%Added–
PLPlanet Labs PBCCOM CL A102,880$559.0K0.4%+102,880NewHistory
DAWNDay One Biopharmaceuticals, Inc.Stock25,751$516.0K0.4%−7,374−22.3%ReducedHistory

Sold out since Q2 2022 (4)

Positions held at the end of Q2 2022 that are gone from this filing.

Positions of Summit Rock Advisors, LP sold out since Q2 2022
SecurityClassShares in Q2 2022Value in Q2 2022% of portfolio in Q2 2022History
WMSAdvanced Drainage Systems, Inc.COM7,448$671.0K0.5%History
CLOVClover Health Investments, Corp.COM CL A210,639$451.0K0.4%History
PHATPhathom Pharmaceuticals, Inc.COM34,100$288.0K0.2%History
DYNDyne Therapeutics, Inc.COM34,887$240.0K0.2%History